{
    "2018-05-14": [
        [
            {
                "time": "2018-04-11",
                "original_text": "Democrats demand answers from AT&T and Novartis about pay...",
                "features": {
                    "keywords": [
                        "Democrats",
                        "demand",
                        "Novartis",
                        "payments",
                        "Trump",
                        "Cohen"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "politics"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-11",
                "original_text": "Democratic senators demand answers from AT&T and Novartis about payments to Trump lawyer Cohen's company",
                "features": {
                    "keywords": [
                        "Democratic",
                        "senators",
                        "Novartis",
                        "payments",
                        "Trump",
                        "Cohen"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "politics"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-05-23",
                "original_text": "Novartis Multiple Sclerosis Drug Gets FDA Nod for Adolescents",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Multiple",
                        "Sclerosis",
                        "Drug",
                        "FDA",
                        "Adolescents"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-01",
                "original_text": "Teva’s Copaxone Maintains Market Share amid Intense Competition",
                "features": {
                    "keywords": [
                        "Teva",
                        "Copaxone",
                        "Market",
                        "Share",
                        "Competition"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "market"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-05-24",
                "original_text": "Novartis’s Cohen Payment Is Subject of Swiss Prosecutor Talks",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Cohen",
                        "Payment",
                        "Swiss",
                        "Prosecutor"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "legal"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-05-25",
                "original_text": "The Swiss Stock Market Clung To A Small Increase On Pharma Strength",
                "features": {
                    "keywords": [
                        "Swiss",
                        "Stock",
                        "Market",
                        "Increase",
                        "Pharma",
                        "Strength"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-28",
                "original_text": "[$$] Novartis' Gilenya Drug Approved",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Gilenya",
                        "Drug",
                        "Approved"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-29",
                "original_text": "[$$] Novartis draws attention of Swiss prosecutors over Michael Cohen deal",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Swiss",
                        "prosecutors",
                        "Michael",
                        "Cohen",
                        "deal"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "legal"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-05-30",
                "original_text": "[$$] Novartis's Gilenya Gets FDA Pediatric Approval",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Gilenya",
                        "FDA",
                        "Pediatric",
                        "Approval"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-05",
                "original_text": "[$$] Greek consultant sues health minister and deputy",
                "features": {
                    "keywords": [
                        "Greek",
                        "consultant",
                        "sues",
                        "health",
                        "minister",
                        "deputy"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "politics"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}